HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited

Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm

Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet

BIELAT SANTORE & COMPANY SELLS SOUTH JERSEY SPORTS BAR & RESTAURANT

New First-in-Class Therapy for Chronic Graft-Versus-Host Disease Approved in Australia[1]

Everads Announces Publication of First-in-Human Clinical Data for Its Suprachoroidal Injector in Ophthalmology Science and Three Presentations at ARVO 2026

Spinogenix to Present Preclinical Results at ARVO 2026 Demonstrating Neuroprotective Effects of Tazbentetol in Glaucoma and Diabetic Retinopathy Models

Understanding Supplements for Toenail Fungus: PureHealth Research Highlights Oregano, Turmeric, and Olive Leaf

VARON Celebrates 5 Years Supporting Easier Breathing for Customers Worldwide

Data at Heart Rhythm 2026 highlight key Boston Scientific therapies

Innovation in health begins by creating the right conditions

Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026

In HelloNation, Pediatric Care Expert Phillip Walker Explains the Importance of a Child's Well Visit and How Families Can Prepare

Why Does PureHealth Research Formulate Its Stress Management Supplements with Ashwagandha and Magnesium?

Best Infrared Saunas of 2026 [Expert Reviewed and Independently Verified]

Growing Interest in Liver Wellness Leads Consumers to Explore PureHealth Research Liver Health Supplements

CureGene Achieves First Participant Dosed in U.S. Pivotal Trial for Evategrel (CG-0255), a Best-in-Class Antiplatelet Drug, Accelerating Global Commercialization

Neuronata-R retains conditional approval in South Korea

Congress Urged to Pass the Vaccine Injury Compensation Modernization Act as a Long-Overdue Path to Justice for COVID Vaccine Injury Victims

TEAMSTERS AT UNIVERSITY OF CHICAGO MEDICAL CENTER TO HOLD TWO-DAY PRACTICE PICKET

Lundbeck presents new data at AAN 2026 highlighting real-world changes in migraine-related cognitive symptoms after starting VYEPTI® (eptinezumab)

PureHealth Research GLP-1 Supplements Blend African Mango and Green Coffee Extract for Daily Satiety Support

USHG CEO Chip Wade named 2026 Gold Plate winner

Muscle Growth Supplements Featuring Magnesium, Ashwagandha and Omega-3s Are Highlighted by PureHealth Research

SAMARITAN'S PURSE EBOLA TREATMENT CENTERS OPEN IN THE EPICENTER OF THE DEADLY OUTBREAK

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL

Marler Clark Urges Parents to Stop Using Nara Organics Whole Milk Organic Powdered Infant Formula Amid Multistate Infant Botulism Outbreak -- Product Sold Nationwide at Target